Page 116 - MEMORIA ANUAL 2021

MEMORIA ANUAL 2021 SOCIEDAD ESPAÑOLA DE
HEMATOLOGÍA Y HEMOTERAPIA
GESMD
FUNDACIÓN ESPAÑOLA DE HEMATOLOGÍA Y HEMOTERAPIA
Horwitz ME, Stiff PJ, Cutler C, Brunstein C, Hanna R, Maziarz RT, Rezvani AR, Karris NA, McGuirk J, Valcárcel D, Schiller GJ, Lindemans CA, Hwang WYK, Koh LP, Keating A, Kha- led Y, Hamerschlak N, Frankfurt O, Peled T, Segalovich I, Blackwell B, Wease S, Freedman LS, Galamidi-Cohen E, Sanz G .
• Adoptive transfer of ex vivo expanded SARS-CoV-2-specific cytotoxic lymphocytes: A viable strategy for COVID-19 immunosuppressed patients?
Transpl Infect Dis. 2021 Aug;23(4):e13602. doi: 10.1111/tid.13602.
Guerreiro M, Aguilar-Gallardo C, Montoro J, Francés-Gómez C, Latorre V, Luna I, Plane- lles D, Carrasco MP, Gómez MD, González-Barberá EM, Aguado C, Sempere A, Solves P, Gómez-Seguí I, Balaguer-Rosello A, Louro A, Perla A, Larrea L, Sanz J, Arbona C, de la Rubia J, Geller R, Sanz MÁ, Sanz G, Luis Piñana J .
• Lymphoid and myeloid immune cell reconstitution after nicotinamide-expanded cord blood transplantation.
Bone Marrow Transplant. 2021 Nov;56(11):2826-33. doi: 10.1038/s41409-021-01417-4.
De Koning C, Tao W, Lacna A, van Veghel K, Horwitz ME, Sanz G, Jagasia MH, Wagner JE, Stiff PJ, Hanna R, Cilloni D, Valcárcel D, Peled T, Galamidi Cohen E, Goshen U, Pandit A, Lindemans CA, Jan Boelens J, Nierkens S .
• A Single-Run Next-Generation Sequencing (NGS) Assay for the Simultaneous Detec- tion of Both Gene Mutations and Large Chromosomal Abnormalities in Patients with Myelodysplastic Syndromes (MDS) and Related Myeloid Neoplasms.
Cancers (Basel). 2021 Apr 18;13(8):1947. doi: 10.3390/cancers13081947. IF: 6,126.
Liquori A, Lesende I, Palomo L, Avetisyán G, Ibáñez M, González-Romero E, Boluda-Nava- rro M, Morote-Faubel M, García-Ruiz C, Martínez-Valiente C, Santiago-Balsera M, Gómez- Seguí I, Sanjuan-Pla A, Sanz MA, Sanz G, Solé F, Such E, Cervera J .
• Analysis of Intratumoral Heterogeneity in Myelodysplastic Syndromes with Isolated del(5q) Using a Single Cell Approach.
Cancers (Basel). 2021 Feb 17;13(4):841. doi: 10.3390/cancers13040841. IF: 6,639.
Acha P, Palomo L, Fuster-Tormo F, Xicoy B, Mallo M, Manzanares A, Grau J, Marcé S, Gra- nada I, Rodríguez-Luaces M, Díez-Campelo M, Zamora L, Solé F .
• Myelodysplastic syndromes with 20q deletion: incidence, prognostic value and impact on response to azacitidine of ASXL1 chromosomal deletion and genetic mutations.
Br J Haematol. 2021 Aug;194(4):708-17. doi: 10.1111/bjh.17675.
Martín I, Villamón E, Abellán R, Calasanz MJ, Irigoyen A, Sanz G, Such E, Mora E, Gutiérrez M, Collado R, García-Serra R, Vara M, Blanco ML, Oiartzabal I, Álvarez S, Bernal T, Gra-
116